• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KDM4A 通过 H3K9me3 调节 HIF-1 水平。

KDM4A regulates HIF-1 levels through H3K9me3.

机构信息

Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, The University of Oxford, Oxford, OX3 7DQ, UK.

Department of Chemistry, Chemistry Research Laboratory, The University of Oxford, Mansfield Road, Oxford, OX1 3TA, UK.

出版信息

Sci Rep. 2017 Sep 11;7(1):11094. doi: 10.1038/s41598-017-11658-3.

DOI:10.1038/s41598-017-11658-3
PMID:28894274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5593970/
Abstract

Regions of hypoxia (low oxygen) occur in most solid tumours and cells in these areas are the most aggressive and therapy resistant. In response to decreased oxygen, extensive changes in gene expression mediated by Hypoxia-Inducible Factors (HIFs) contribute significantly to the aggressive hypoxic tumour phenotype. In addition to HIFs, multiple histone demethylases are altered in their expression and activity, providing a secondary mechanism to extend the hypoxic signalling response. In this study, we demonstrate that the levels of HIF-1α are directly controlled by the repressive chromatin mark, H3K9me3. In conditions where the histone demethylase KDM4A is depleted or inactive, H3K9me3 accumulates at the HIF-1α locus, leading to a decrease in HIF-1α mRNA and a reduction in HIF-1α stabilisation. Loss of KDM4A in hypoxic conditions leads to a decreased HIF-1α mediated transcriptional response and correlates with a reduction in the characteristics associated with tumour aggressiveness, including invasion, migration, and oxygen consumption. The contribution of KDM4A to the regulation of HIF-1α is most robust in conditions of mild hypoxia. This suggests that KDM4A can enhance the function of HIF-1α by increasing the total available protein to counteract any residual activity of prolyl hydroxylases.

摘要

缺氧(低氧)区域出现在大多数实体瘤中,这些区域的细胞最具侵袭性和抗治疗性。为了应对氧气减少,缺氧诱导因子(HIFs)介导的广泛基因表达变化对侵袭性缺氧肿瘤表型有重要贡献。除了 HIFs 之外,多种组蛋白去甲基酶的表达和活性也发生改变,为延长缺氧信号反应提供了次要机制。在这项研究中,我们证明 HIF-1α 的水平直接受到抑制性染色质标记 H3K9me3 的控制。在组蛋白去甲基酶 KDM4A 耗尽或失活的情况下,H3K9me3 在 HIF-1α 基因座上积累,导致 HIF-1α mRNA 减少和 HIF-1α 稳定性降低。在缺氧条件下失去 KDM4A 会导致 HIF-1α 介导的转录反应减少,并与肿瘤侵袭性相关特征的减少相关,包括侵袭、迁移和耗氧量。在轻度缺氧条件下,KDM4A 对 HIF-1α 的调节作用最为显著。这表明 KDM4A 可以通过增加总可用蛋白来增强 HIF-1α 的功能,以抵消脯氨酰羟化酶的任何残留活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/5593970/784ff9131ee4/41598_2017_11658_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/5593970/db37eac4843c/41598_2017_11658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/5593970/1e88ab8dd683/41598_2017_11658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/5593970/2656bce0e608/41598_2017_11658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/5593970/784ff9131ee4/41598_2017_11658_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/5593970/db37eac4843c/41598_2017_11658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/5593970/1e88ab8dd683/41598_2017_11658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/5593970/2656bce0e608/41598_2017_11658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f7/5593970/784ff9131ee4/41598_2017_11658_Fig4_HTML.jpg

相似文献

1
KDM4A regulates HIF-1 levels through H3K9me3.KDM4A 通过 H3K9me3 调节 HIF-1 水平。
Sci Rep. 2017 Sep 11;7(1):11094. doi: 10.1038/s41598-017-11658-3.
2
Intermittent hypoxia enhances the expression of hypoxia inducible factor HIF1A through histone demethylation.间歇性低氧通过组蛋白去甲基化增强低氧诱导因子 HIF1A 的表达。
J Biol Chem. 2022 Nov;298(11):102536. doi: 10.1016/j.jbc.2022.102536. Epub 2022 Sep 27.
3
Insights into The Function and Regulation of Jumonji C Lysine Demethylases as Hypoxic Responsive Enzymes.深入探讨 Jumonji C 赖氨酸去甲基酶作为缺氧反应性酶的功能和调控机制。
Curr Protein Pept Sci. 2020;21(7):642-654. doi: 10.2174/1389203721666191231104225.
4
Histone demethylase KDM4A plays an oncogenic role in nasopharyngeal carcinoma by promoting cell migration and invasion.组蛋白去甲基化酶 KDM4A 通过促进细胞迁移和侵袭在鼻咽癌中发挥致癌作用。
Exp Mol Med. 2021 Aug;53(8):1207-1217. doi: 10.1038/s12276-021-00657-0. Epub 2021 Aug 12.
5
HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway.HIF-1α 激活的长非编码 RNA KDM4A-AS1 通过 miR-411-5p/KPNA2/AKT 通路促进肝细胞癌进展。
Cell Death Dis. 2021 Dec 13;12(12):1152. doi: 10.1038/s41419-021-04449-2.
6
HIF-1α/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury.缺氧和高血糖诱导的血管细胞损伤后,HIF-1α/JMJD1A 信号转导调节炎症和氧化应激。
Cell Mol Biol Lett. 2021 Sep 3;26(1):40. doi: 10.1186/s11658-021-00283-8.
7
Lysine demethylase KDM6B regulates HIF-1α-mediated systemic and cellular responses to intermittent hypoxia.赖氨酸去甲基酶 KDM6B 调节低氧诱导因子-1α 介导的间歇性低氧的全身和细胞反应。
Physiol Genomics. 2021 Sep 1;53(9):385-394. doi: 10.1152/physiolgenomics.00045.2021. Epub 2021 Jul 23.
8
High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1α (HIF-1α) predict patients' worse prognosis in human hepatocellular carcinomas.组蛋白H3赖氨酸9的高甲基化水平与缺氧诱导因子1α(HIF-1α)的激活相关,这预示着人类肝细胞癌患者的预后更差。
Cancer Genet. 2020 Jul;245:17-26. doi: 10.1016/j.cancergen.2020.04.077. Epub 2020 May 18.
9
Fentanyl activates hypoxia-inducible factor 1 in neuronal SH-SY5Y cells and mice under non-hypoxic conditions in a μ-opioid receptor-dependent manner.芬太尼在非缺氧条件下通过μ-阿片受体依赖的方式激活神经元 SH-SY5Y 细胞和小鼠中的缺氧诱导因子 1。
Eur J Pharmacol. 2011 Sep 30;667(1-3):144-52. doi: 10.1016/j.ejphar.2011.06.014. Epub 2011 Jun 17.
10
Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.缺氧诱导因子-1(HIF-1)通过诱导HIF-α-脯氨酰-4-羟化酶来促进其自身降解。
Biochem J. 2004 Aug 1;381(Pt 3):761-7. doi: 10.1042/BJ20040620.

引用本文的文献

1
Epigenetic drugs against human DNA viruses and retroviruses.针对人类DNA病毒和逆转录病毒的表观遗传药物。
Antiviral Res. 2025 Aug;240:106218. doi: 10.1016/j.antiviral.2025.106218. Epub 2025 Jun 23.
2
R-2-hydroxyglutarate-mediated inhibition of KDM4A compromises telomere integrity.R-2-羟基戊二酸介导的KDM4A抑制作用损害端粒完整性。
Nucleic Acids Res. 2025 Jun 6;53(11). doi: 10.1093/nar/gkaf512.
3
Inhibiting the Histone Demethylase Kdm4a Restrains Cardiac Fibrosis After Myocardial Infarction by Promoting Autophagy in Premature Senescent Fibroblasts.

本文引用的文献

1
Highly selective inhibition of histone demethylases by de novo macrocyclic peptides.新型大环肽对组蛋白去甲基化酶的高选择性抑制作用。
Nat Commun. 2017 Apr 6;8:14773. doi: 10.1038/ncomms14773.
2
Regulation of hypoxia responses by flavin adenine dinucleotide-dependent modulation of HIF-1α protein stability.通过黄素腺嘌呤二核苷酸依赖性调节缺氧诱导因子-1α蛋白稳定性来调控缺氧反应
EMBO J. 2017 Apr 13;36(8):1011-1028. doi: 10.15252/embj.201694408. Epub 2017 Mar 9.
3
The Activity of JmjC Histone Lysine Demethylase KDM4A is Highly Sensitive to Oxygen Concentrations.
抑制组蛋白去甲基化酶Kdm4a通过促进早衰成纤维细胞自噬来抑制心肌梗死后的心脏纤维化。
Adv Sci (Weinh). 2025 Jun;12(21):e2414830. doi: 10.1002/advs.202414830. Epub 2025 Apr 15.
4
The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy.H3K9me3 读写擦修饰酶在癌症免疫治疗中的作用。
Int J Mol Sci. 2024 Oct 25;25(21):11466. doi: 10.3390/ijms252111466.
5
Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate.聚焦筛选鉴定人 TET 加氧酶对致癌代谢物 2-羟戊二酸的不同敏感性。
J Med Chem. 2024 Mar 28;67(6):4525-4540. doi: 10.1021/acs.jmedchem.3c01820. Epub 2024 Jan 31.
6
Effect and mechanism of hypoxia on differentiation of porcine-induced pluripotent stem cells into vascular endothelial cells.缺氧对猪诱导多能干细胞向血管内皮细胞分化的影响及机制
In Vitro Cell Dev Biol Anim. 2024 Jan;60(1):9-22. doi: 10.1007/s11626-023-00833-8. Epub 2023 Dec 26.
7
Astrocyte KDM4A mediates chemokines and drives neutrophil infiltration to aggravate cerebral ischemia and reperfusion injury.星形胶质细胞 KDM4A 介导趋化因子并驱动中性粒细胞浸润,加重脑缺血再灌注损伤。
J Cereb Blood Flow Metab. 2024 Apr;44(4):491-507. doi: 10.1177/0271678X231216158. Epub 2023 Nov 26.
8
Structure-guided optimisation of -hydroxythiazole-derived inhibitors of factor inhibiting hypoxia-inducible factor-α.基于结构的缺氧诱导因子-α抑制因子的β-羟基噻唑衍生物抑制剂的优化
Chem Sci. 2023 Oct 27;14(43):12098-12120. doi: 10.1039/d3sc04253g. eCollection 2023 Nov 8.
9
Oxygen-regulated post-translation modifications as master signalling pathway in cells.氧调节的翻译后修饰作为细胞中的主要信号通路。
EMBO Rep. 2023 Dec 6;24(12):e57849. doi: 10.15252/embr.202357849. Epub 2023 Oct 25.
10
Searching for molecular hypoxia sensors among oxygen-dependent enzymes.在氧依赖酶中寻找分子缺氧传感器。
Elife. 2023 Jul 26;12:e87705. doi: 10.7554/eLife.87705.
JmjC组蛋白赖氨酸去甲基化酶KDM4A的活性对氧浓度高度敏感。
ACS Chem Biol. 2017 Apr 21;12(4):1011-1019. doi: 10.1021/acschembio.6b00958. Epub 2017 Feb 20.
4
Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.组蛋白去甲基化酶JMJD2A通过转录因子ETV1驱动前列腺癌发生。
J Clin Invest. 2016 Feb;126(2):706-20. doi: 10.1172/JCI78132. Epub 2016 Jan 5.
5
5-Carboxy-8-hydroxyquinoline is a Broad Spectrum 2-Oxoglutarate Oxygenase Inhibitor which Causes Iron Translocation.5-羧基-8-羟基喹啉是一种导致铁转运的广谱2-氧代戊二酸加氧酶抑制剂。
Chem Sci. 2013 Aug 1;4(8):3110-3117. doi: 10.1039/C3SC51122G.
6
HIF3α: the little we know.缺氧诱导因子3α:我们所了解的甚少。
FEBS J. 2016 Mar;283(6):993-1003. doi: 10.1111/febs.13572. Epub 2015 Nov 14.
7
Epigenetic Therapy for Solid Tumors: Highlighting the Impact of Tumor Hypoxia.实体瘤的表观遗传治疗:强调肿瘤缺氧的影响
Genes (Basel). 2015 Sep 25;6(4):935-56. doi: 10.3390/genes6040935.
8
Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases.贝蒂反应能够高效合成2-氧代戊二酸加氧酶的8-羟基喹啉抑制剂。
Chem Commun (Camb). 2015 Oct 28;51(84):15458-61. doi: 10.1039/c5cc06095h.
9
In Vitro Radiosensitization of Esophageal Cancer Cells with the Aminopeptidase Inhibitor CHR-2797.氨肽酶抑制剂CHR - 2797对食管癌细胞的体外放射增敏作用
Radiat Res. 2015 Sep;184(3):259-65. doi: 10.1667/RR14150.1. Epub 2015 Aug 20.
10
Hypoxia drives transient site-specific copy gain and drug-resistant gene expression.缺氧驱动瞬时位点特异性拷贝数增加和耐药基因表达。
Genes Dev. 2015 May 15;29(10):1018-31. doi: 10.1101/gad.259796.115.